Characterization of the host immune response in human ganglia after herpes zoster

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8861-8870

  Gowrishankar, Kavitha ^a   Steain, Megan ^a   Cunningham, Anthony L ^a   Rodriguez, Michael ^b   Blumbergs, Peter ^c   Slobedman, Barry ^a   Abendroth, Allison ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Sydney South West Area Health Service ^*  (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BRAIN VASCULITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DEATH; DENDRITIC CELL; DONOR; HERPES ZOSTER; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; NATURAL KILLER CELL; NERVE CELL; PHENOTYPE; PRIORITY JOURNAL; RASH; SENSORY GANGLION; SPINAL GANGLION; VARICELLA ZOSTER VIRUS; ADOLESCENT; FEMALE; GANGLION; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; POSTHERPETIC NEURALGIA; VIROLOGY;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

ADOLESCENT; ADULT; AGED, 80 AND OVER; FEMALE; GANGLIA; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; NEURONS;

EID: 77956630037     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01020-10     Document Type: Article

References (78)

1. Abendroth, A., I. Lin, B. Slobedman, H. Ploegh, and A. M. Arvin. 2001. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 75:4878-4888.
2. Anderson, P., C. Nagler-Anderson, C. O'Brien, H. Levine, S. Watkins, H. S. Slayter, M. L. Blue, and S. F. Schlossman. 1990. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J. Immunol. 144:574-582.
3. Arvin, A. M. 1999. Chickenpox (varicella). Contrib. Microbiol. 3:96-110.
4. Arvin, A. M. 2000. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 6:219-230.
5. Arvin, A. M. 2001. Varicella-zoster virus., p. 2731-2768. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott, Williams and Wilkins., Philadelphia, PA.
6. Azarkh, Y., D. Gilden, and R. J. Cohrs. Molecular characterization of varicella zoster virus in latently infected human ganglia: physical state and abundance of VZV DNA, quantitation of viral transcripts and detection of VZV-specific proteins. Curr. Top. Microbiol. Immunol., in press.
7. Burgoon, C. F., Jr., J. S. Burgoon, and G. D. Baldridge. 1957. The natural history of herpes zoster. JAMA 164:265-269.
8. Cohen, J., and S. E. Straus. 2001. Varicella zoster virus and its replication, p. 2707-2730. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Raven Press, New York, NY.
9. Cohen, J. I. 1998. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J. Infect. Dis. 177:1390-1393.
10. Cohen, J. I., P. A. Brunell, S. E. Straus, and P. R. Krause. 1999. Recent advances in varicella-zoster virus infection. Ann. Intern. Med. 130:922-932.
11. Cohrs, R. J., D. H. Gilden, P. R. Kinchington, E. Grinfeld, and P. G. Kennedy. 2003. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J. Virol. 77:6660-6665.
12. Cohrs, R. J., D. H. Gilden, and R. Mahalingam. 2004. Varicella zoster virus latency, neurological disease and experimental models: an update. Front. Biosci. 9:751-762.
13. Croen, K. D., J. M. Ostrove, L. J. Dragovic, and S. E. Straus. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. U. S. A. 85:9773-9777.
14. Denny-Brown, D., R. Adam, and P. Fitzgerald. 1944. Pathologic features of herpes zoster. AMA Arch. Derm. 75:193-196.
15. Dworkin, R., and K. E. Schmader. 2001. Herpes zoster and post herpetic neuralgia, p. 39-64. In C. P. N. Watson and A. A. Gershon (ed.), The epidemiology and natural history of herpes zoster and postherpetic neuralgia, 2nd ed. Elsevier Press, New York, NY.
16. Dworkin, R. H., R. W. Johnson, J. Breuer, J. W. Gnann, M. J. Levin, M. Backonja, A. A. Gershon, M. L. Haanpää, M. W. McKendrick, A. L. Oaklander, M. N. Oxman, P. K. D. Pavan-Langston, M. C. Rowbotham, K. E. Schmader, B. R. Stacey, S. K. Tyring, A. J. van Wijck, M. S. Wallace,, S. W. Wassilew, and R. J. Whitley. 2007. Recommendations for the management of herpes zoster. Clin. Infect. Dis. 44:S1-S26.
17. Eisfeld, A. J., M. B. Yee, A. Erazo, A. Abendroth, and P. R. Kinchington. 2007. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J. Virol. 81:9034-9049.
18. Esiri, M. M., and A. H. Tomlinson. 1972. Herpes zoster: demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J. Neurol. Sci. 15:35-48.
19. Gilden, D., B. K. Kleinschmidt-DeMasters, J. J. LaGuardia, R. Mahalingam, and R. Cohrs. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342:635-645.
20. Gilden, D., Y. Rozenman, R. S. Murray, M. Devlin, and A. Vafai. 1987. Detection of varicella-zoster nucleic acid in neurons of normal human thoracic ganglia. Ann. Neurol. 22:377-380.
21. Gilden, D. H., R. Mahalingam, A. N. Dueland, and R. Cohrs. 1992. Herpes zoster: pathogenesis and latency. Progr. Med. Vir. 36:19-75.
22. Gilden, D. H., R. S. Murray, M. Wellish, B. K. Kleinschmidt-DeMasters, and A. Vafai. 1988. Chronic progressive varicella-zoster virus encephalitis in an AIDS patient. Neurology 38:1150-1153.
23. Gnann, J. 2008. Preventing herpes zoster. J. Pain 9:S31-S36.
24. Gnann, J. W., Jr., and R. J. Whitley. 2002. Clinical practice. Herpes zoster. N. Engl. J. Med. 347:340-346.
25. Gowrishankar, K., B. Slobedman, A. L. Cunningham, M. Miranda-Saksena, R. A. Boadle, and A. Abendroth. 2007. Productive varicella-zoster virus infection of cultured intact human ganglia. J. Virol. 81:6752-6756.
26. Griffiths, G. M., and C. Mueller. 1991. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol. Today 12:415-419.
27. Head, H., and A. W. Campbell. 1900. The pathology of herpes zoster and its bearing on sensory localization. Brain 23:353-523.
28. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
29. Hope-Simpson, R. E. 1975. Postherpetic neuralgia. J. R. Coll. Gen. Pract. 25:571-575.
30. Johnson, A. J., C. F. Chu, and G. N. Milligan. 2008. Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J. Virol. 82:9678-9688.
31. Joly, E., L. Mucke, and M. B. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253:1283-1285.
32. Kennedy, P. G. 2002. Varicella-zoster virus latency in human ganglia. Rev. Med. Virol. 12:327-334.
33. Kennedy, P. G., E. Grinfeld, and J. E. Bell. 2000. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 74: 11893-11898.
34. Khanna, K. M., R. H. Bonneau, P. R. Kinchington, and R. L. Hendricks. 2003. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593-603.
35. Kinchington, P., and J. I. Cohen. 2000. Varicella zoster virus proteins, p. 74-104. In A. Gershon (ed.), Varicella-zoster virus: virology and clinical management. Cambridge University Press, Cambridge, United Kingdom.
36. Kinchington, P. R. 1999. Latency of varicella zoster virus; a persistently perplexing state. Front. Biosci. 4:D200-D211.
37. Knickelbein, J. E., K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L. Hendricks. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
38. Kost, R. G., and S. E. Straus. 1996. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N. Engl. J. Med. 335:32-42.
39. Kost, R. G., and S. E. Straus. 1997. Postherpetic neuralgia. Predicting and preventing risk. Arch. Intern. Med. 157:1166-1167.
40. Ku, C. C., J. Besser, A. Abendroth, C. Grose, and A. M. Arvin. 2005. Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J. Virol. 79: 2651-2658.
41. Ku, C. C., J. A. Padilla, C. Grose, E. C. Butcher, and A. M. Arvin. 2002. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J. Virol. 76: 11425-11433.
42. Ku, C. C., L. Zerboni, H. Ito, B. S. Graham, M. Wallace, and A. M. Arvin. 2004. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J. Exp. Med. 200:917-925.
43. Lancaster, T., C. Silagy, and S. Gray. 1995. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br. J. Gen. Pract. 45:39-45.
44. Leinweber, B., H. Kerl, and L. Cerroni. 2006. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am. J. Surg. Pathol. 30:50-58.
45. Li, Q., N. Chen, J. Yang, M. Zhou, D. Zhou, Q. Zhang, and L. He. 2009. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst. Rev. CD006866.
46. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264-271.
47. Lungu, O., P. W. Annunziato, A. Gershon, S. M. Staugaitis, D. Josefson, P. LaRussa, and S. J. Silverstein. 1995. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc. Natl. Acad. Sci. U. S. A. 92:10980-10984.
48. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. U. S. A. 95: 7080-7085.
49. Mahalingam, R., M. Wellish, R. Cohrs, S. Debrus, J. Piette, B. Rentier, and D. H. Gilden. 1996. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. U. S. A. 93:2122-2124.
50. Masson, D., and J. Tschopp. 1987. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49:679-685.
51. Morizane, S., D. Suzuki, K. Tsuji, T. Oono, and K. Iwatsuki. 2005. The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles. Br. J. Dermatol. 153:981-986.
52. Nagashima, K., M. Nakazawa, and H. Endo. 1975. Pathology of the human spinal ganglia in varicella-zoster virus infection. Acta Neuropathol. 33:105-117.
53. Oxman, M. 2000. Clinical manifestations of herpes zoster. In A. M. Arvin and A. A. Gershon (ed.), Varicella zoster virus: virology and clinical management. Cambridge University Press, Cambridge, United Kingdom.
54. Oxman, M. N., M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, A. Weinberg, K. D. Boardman, H. M. Williams, J. H. Zhang, P. N. Peduzzi, C. E. Beisel, V. A. Morrison, J. C. Guatelli, P. A. Brooks, C. A. Kauffman, C. T. Pachucki, K. M. Neuzil, R. F. Betts, P. F. Wright, M. R. Griffin, P. Brunell, N. E. Soto, A. R. Marques, S. K. Keay, R. P. Goodman, D. J. Cotton, J. W. Gnann, Jr., J. Loutit, M. Holodniy, W. A. Keitel, G. E. Crawford, S. S. Yeh, Z. Lobo, J. F. Toney, R. N. Greenberg, P. M. Keller, R. Harbecke, A. R. Hayward, M. R. Irwin, T. C. Kyriakides, C. Y. Chan, I. S. Chan, W. W. Wang, P. W. Annunziato, and J. L. Silber. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352:2271-2284.
55. Pereira, R. A., D. C. Tscharke, and A. Simmons. 1994. Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J. Exp. Med. 180:841-850.
56. Portenoy, R. K. 1986. Postherpetic neuralgia: a workable treatment plan. Geriatrics 41:34-36, 47-48.
57. Ramakrishna, C., S. A. Stohlman, R. D. Atkinson, M. J. Shlomchik, and C. C. Bergmann. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J. Immunology 168:1204-1211.
58. Reichelt, M., L. Zerboni, and A. M. Arvin. 2008. Mechanisms of varicellazoster virus neuropathogenesis in human dorsal root ganglia. J. Virol. 82: 3971-3983.
59. Romijn, H. J., J. F. van Uum, I. Breedijk, J. Emmering, I. Radu, and C. W. Pool. 1999. Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J. Histochem. Cytochem. 47:229-236.
60. Sadzot-Delvaux, C., and B. Rentier. 2000. Animal models of infection, p. 169-186. In A. M. Arvin and A. A. Gershon (ed.), Varicella zoster virus; virology and clinical management. Cambridge University Press, Cambridge, United Kingdom.
61. Sitati, E. M., and M. S. Diamond. 2006. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80:12060-12069.
62. Steiner, I., P. G. Kennedy, and A. R. Pachner. 2007. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurology. 6:1015-1028.
63. Tishon, A., H. Lewicki, A. Andaya, D. McGavern, L. Martin, and M. B. Oldstone. 2006. CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347:234-245.
64. Turnley, A. M., R. Starr, and P. F. Bartlett. 2002. Failure of sensory neurons to express class I MHC is due to differential SOCS1 expression. J. Neuroimmunol. 123:35-40.
65. Tyring, S., R. A. Barbarash, J. E. Nahlik, A. Cunningham, J. Marley, M. Heng, T. Jones, T. Rea, R. Boon, and R. Saltzman. 1995. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann. Intern. Med. 123:89-96.
66. Verjans, G. M., R. Q. Hintzen, J. M. van Dun, A. Poot, J. C. Milikan, J. D. Laman, A. W. Langerak, P. R. Kinchington, and A. D. Osterhaus. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.
67. Vossen, M. T., M. H. Biezeveld, M. D. de Jong, M. R. Gent, P. A. Baars, I. A. von Rosenstiel, R. A. van Lier, and T. W. Kuijpers. 2005. Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella. J. Infect. Dis. 191:198-206.
68. Wareham, D. W., and J. Breuer. 2007. Herpes zoster. BMJ. 334:1211-1215.
69. Watson, C. P., J. H. Deck, C. Morshead, D. Van der Kooy, and R. J. Evans. 1991. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44:105-117.
70. Watson, C. P., C. Morshead, D. Van der Kooy, J. Deck, and R. J. Evans. 1988. Post-herpetic neuralgia: post-mortem analysis of a case. Pain 34:129-138.
71. Watson, C. P., V. R. Watt, M. Chipman, N. Birkett, and R. J. Evans. 1991. The prognosis with postherpetic neuralgia. Pain 46:195-199.
72. Watson, C. P. N., and J. H. Deck. 1993. The neuropathology of herpes zoster with particular reference to postherpetic neuralgia and its pathogenesis, vol. 8. Elsevier, New York, NY.
73. Watson, P. N., and R. J. Evans. 1986. Postherpetic neuralgia. A review. Arch. Neurol. 43:836-840.
74. Wenzel, J., I. Gütgemann, M. Distelmaier, M. Uerlich, S. Mikus, T. Bieber, and T. Tüting. 2005. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J. Am. Acad. Dermatol. 53:422-427.
75. Wood, M. J., R. W. Johnson, M. W. McKendrick, J. Taylor, B. K. Mandal, and J. Crooks. 1994. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med. 330:896-900.
76. Wu, C. L., and S. N. Raja. 2008. An update on the treatment of postherpetic neuralgia. J. Pain S19-S30.
77. Zerboni, L., C. C. Ku, C. D. Jones, J. L. Zehnder, and A. M. Arvin. 2005. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Pro. Natl. Acad. Sci. U. S. A. 102:6490-6495.
78. Zerboni, L., R. A. Sobel, V. Ramachandran, J. Rajamani, W. Ruyechan, A. Abendroth, and A. Arvin. 2010. Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia. J. Virol. 84:3421-3430.